Research Topics
| David G VosslerSummaryAffiliation: Swedish Medical Center Country: USA Publications
|
Detail Information
Publications
Serum and CSF glutamine levels in valproate-related hyperammonemic encephalopathyDavid G Vossler
Swedish Epilepsy Center, Swedish Medical Center, Department of Neurology, University of Washington, Seattle 98122, USA
Epilepsia 43:154-9. 2002..To investigate ammonia and glutamine levels in valproate (VPA)-related hyperammonemic encephalopathy (VHE)...
Ictal stuttering: a sign suggestive of psychogenic nonepileptic seizuresD G Vossler
Epilepsy Center and Clinical Neurophysiology Laboratories, Swedish Neuroscience Institute, 801 Broadway 901, Seattle, WA 98122, USA
Neurology 63:516-9. 2004..To determine if ictal stuttering (IS) is more common among patients with psychogenic nonepileptic seizures (PNES) than patients with epileptic seizures (ES)...
Neocortical gliosis in temporal lobe epilepsy: gender-based differencesMichael J Doherty
Swedish Epilepsy Center, 801 Broadway, Seattle, WA 98122, USA
Epilepsia 48:1455-9. 2007..In this study, we assess if neocortical or hippocampal pathologies from patients who underwent en bloc anteriomedial temporal lobectomy (AMTR) for medically refractory epilepsy differ by gender...
Intracranial EEG in temporal lobe epilepsy: location of seizure onset relates to degree of hippocampal pathologyDavid G Vossler
Epilepsy Center and Clinical Neurophysiology Laboratories, Swedish Neuroscience Institute, Seattle, Washington 98122, USA
Epilepsia 45:497-503. 2004..To determine whether the specific location of electrographic seizure onset in the temporal lobe is related to hippocampal pathology in temporal lobe epilepsy (TLE)...
Zonisamide for the treatment of myoclonic seizures in progressive myoclonic epilepsy: an open-label studyDavid G Vossler
Epilepsy Center, Washington Neuroscience Institute, Renton, Washington 98055, USA
Epileptic Disord 10:31-4. 2008..To examine the safety and efficacy of zonisamide in treating myoclonic seizures associated with progressive myoclonic epilepsy (PME), in an open-label setting...
